Cash flow Universal Health Services, Inc.

Equities

UHS

US9139031002

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 02:58:18 2025-12-09 pm EST			5-day change	1st Jan Change
224.95 ^USD	-0.52%		-5.55%	+25.64%

Dec. 02	Guggenheim Adjusts Price Target on Universal Health Services to $274 From $253, Maintains Buy Rating	MT
Nov. 24	Health insurers rise on report Trump considering ACA subsidy extension	RE

ecaf4.xADxnZurcUbIMQPfgTcFrnJno0xh1hjzGx-miAVANZ0.93q9rPLPNDKLB1G6xGQw4josxh4PjHG9aHrl-EovAf6SV7Tr-eIHKKdddA

Published financial data: UNIVERSAL HEALTH SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	11.56B	12.64B	13.4B	14.28B	15.83B
Total Revenues	11.56B	12.64B	13.4B	14.28B	15.83B
Cost of Goods Sold, Total	6.9B	7.59B	8.24B	8.64B	9.11B
Gross Profit	4.66B	5.05B	5.16B	5.64B	6.72B
Selling General & Admin Expenses, Total	116M	119M	132M	141M	146M
Depreciation & Amortization - (IS)	510M	533M	582M	568M	585M
Other Operating Expenses	2.67B	3B	3.39B	3.76B	4.31B
Other Operating Expenses, Total	3.3B	3.66B	4.1B	4.47B	5.04B
Operating Income	1.36B	1.39B	1.06B	1.18B	1.68B
Interest Expense, Total	-109M	-85.27M	-127M	-207M	-188M
Interest And Investment Income	3.65M	3.3M	2.18M	2.47M	3.32M
Net Interest Expenses	-105M	-81.97M	-125M	-205M	-184M
Income (Loss) On Equity Invest.	1.1M	6.2M	1.2M	874K	1.1M
Other Non Operating Income (Expenses)	2.07M	5.99M	-13.41M	-31.06M	-769K
EBT, Excl. Unusual Items	1.26B	1.32B	924M	940M	1.5B
Gain (Loss) On Sale Of Investments	-4M	-	-	-	-
Asset Writedown	-	-14.39M	-57.55M	-	-
Other Unusual Items	-1M	-16.83M	-	-	-3.16M
EBT, Incl. Unusual Items	1.25B	1.29B	866M	940M	1.5B
Income Tax Expense	299M	306M	209M	221M	335M
Earnings From Continuing Operations	953M	988M	657M	719M	1.16B
Net Income to Company	953M	988M	657M	719M	1.16B
Minority Interest	-8.84M	3.96M	18.63M	-1.51M	-21.01M
Net Income - (IS)	944M	992M	676M	718M	1.14B
Preferred Dividend and Other Adjustments	2.98M	2.06M	748K	308K	50K
Net Income to Common Incl Extra Items	941M	990M	675M	717M	1.14B
Net Income to Common Excl. Extra Items	941M	990M	675M	717M	1.14B
Per Share Items
Net EPS - Basic	11.06	11.99	9.23	10.35	17.16
Basic EPS - Continuing Operations	11.06	11.99	9.23	10.35	17.16
Basic Weighted Average Shares Outstanding	85.06M	82.52M	73.12M	69.32M	66.55M
Net EPS - Diluted	10.99	11.82	9.14	10.23	16.82
Diluted EPS - Continuing Operations	10.99	11.82	9.14	10.23	16.82
Diluted Weighted Average Shares Outstanding	85.59M	83.69M	73.83M	70.12M	67.9M
Normalized Basic EPS	9.13	10.08	8.15	8.46	13.78
Normalized Diluted EPS	9.08	9.94	8.07	8.36	13.51
Dividend Per Share	0.2	0.8	0.8	0.8	0.8
Payout Ratio	1.84	6.65	8.65	7.73	4.67
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.87B	1.93B	1.64B	1.74B	2.27B
EBITA	1.36B	1.39B	1.06B	1.18B	1.68B
EBIT	1.36B	1.39B	1.06B	1.18B	1.68B
EBITDAR	1.99B	2.05B	1.77B	1.88B	2.42B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	23.9	23.64	24.16	23.51	22.35
Current Domestic Taxes	312M	321M	212M	233M	357M
Current Foreign Taxes	13.98M	13.75M	14.74M	6.5M	10.96M
Total Current Taxes	326M	335M	227M	239M	368M
Deferred Domestic Taxes	-24.5M	-31.06M	-16.04M	-21.32M	-32.14M
Deferred Foreign Taxes	-2.5M	1.52M	-1.51M	3.37M	-1.32M
Total Deferred Taxes	-26.99M	-29.54M	-17.55M	-17.96M	-33.46M
Normalized Net Income	777M	832M	596M	586M	917M
Interest Capitalized	4.26M	4.41M	8.6M	24.4M	38.9M
Interest on Long-Term Debt	113M	89.68M	136M	232M	226M
Non-Cash Pension Expense	-1.9M	-2M	-1.5M	-77K	-403K
Supplemental Operating Expense Items
Net Rental Expense, Total	116M	119M	132M	141M	146M
Imputed Operating Lease Interest Expense	24.75M	19.48M	29.11M	49.13M	51.4M
Imputed Operating Lease Depreciation	91.31M	99.38M	103M	91.89M	95.04M
Stock-Based Comp., Other (Total)	65.9M	73.7M	85.3M	87.72M	99.35M
Total Stock-Based Compensation	65.9M	73.7M	85.3M	87.72M	99.35M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.22B	115M	103M	119M	126M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.22B	115M	103M	119M	126M
Accounts Receivable, Total	1.73B	1.75B	2.02B	2.24B	2.18B
Total Receivables	1.73B	1.75B	2.02B	2.24B	2.18B
Inventory	190M	207M	219M	217M	221M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	138M	195M	198M	237M	292M
Total Current Assets	3.28B	2.26B	2.54B	2.81B	2.82B
Gross Property Plant And Equipment	10.22B	11.14B	11.54B	12.21B	13.06B
Accumulated Depreciation	-4.51B	-4.9B	-5.17B	-5.65B	-6.07B
Net Property Plant And Equipment	5.71B	6.24B	6.37B	6.56B	6.99B
Long-term Investments	157M	184M	202M	170M	171M
Goodwill	3.88B	3.96B	3.91B	3.93B	3.93B
Other Intangibles, Total	82.59M	81.04M	78.1M	77.02M	76.27M
Deferred Tax Assets Long-Term	22.69M	45.71M	68.4M	85.63M	118M
Deferred Charges Long-Term	4.98M	6.52M	6.26M	6.97M	9.4M
Other Long-Term Assets, Total	335M	309M	319M	325M	355M
Total Assets	13.48B	13.09B	13.49B	13.97B	14.47B
Liabilities
Accounts Payable, Total	571M	659M	637M	614M	632M
Accrued Expenses, Total	1.1B	1.2B	1.12B	1.19B	1.45B
Current Portion of Long-Term Debt	330M	45.67M	78.4M	124M	34.78M
Current Portion of Leases	61.88M	67.22M	70.82M	74.65M	79.93M
Current Income Taxes Payable	44.42M	10.72M	4.61M	2.05M	14.22M
Other Current Liabilities	376M	6K	2.4M	7.29M	-
Total Current Liabilities	2.48B	1.98B	1.91B	2.01B	2.21B
Long-Term Debt	3.47B	4.07B	4.65B	4.72B	4.38B
Long-Term Leases	329M	381M	468M	452M	463M
Pension & Other Post Retirement Benefits	18M	20M	19M	22M	23M
Deferred Tax Liability Non Current	5.58M	-	-	-	-
Other Non Current Liabilities	763M	445M	469M	562M	633M
Total Liabilities	7.07B	6.9B	7.52B	7.77B	7.71B
Common Stock, Total	851K	771K	710K	672K	650K
Retained Earnings	6.27B	6.06B	5.93B	6.14B	6.66B
Comprehensive Income and Other	48.12M	30.29M	-9.67M	9.29M	7.2M
Total Common Equity	6.32B	6.09B	5.92B	6.15B	6.67B
Minority Interest	89.39M	109M	49.46M	52.9M	96.61M
Total Equity	6.41B	6.2B	5.97B	6.2B	6.76B
Total Liabilities And Equity	13.48B	13.09B	13.49B	13.97B	14.47B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	85.09M	74.81M	70.67M	67.22M	65M
ECS Total Common Shares Outstanding	85.06M	77.09M	70.63M	67.18M	64.98M
Book Value / Share	74.26	78.99	83.83	91.53	102.59
Tangible Book Value	2.35B	2.05B	1.93B	2.14B	2.66B
Tangible Book Value Per Share	27.65	26.54	27.37	31.85	40.89
Total Debt	4.19B	4.56B	5.27B	5.37B	4.96B
Net Debt	2.97B	4.44B	5.17B	5.25B	4.83B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-8.45M	-11.33M	-9.35M	-12.79M	-14.99M
Debt Equivalent Oper. Leases	928M	951M	1.05B	1.13B	1.17B
Minority Interest, Total (Incl. Fin. Div)	89.39M	109M	49.46M	52.9M	96.61M
Equity Method Investments, Total	5.4M	9.4M	8.4M	7M	5.8M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	190M	207M	219M	217M	221M
Land - (BS)	665M	733M	727M	737M	746M
Buildings, Total	6.03B	6.51B	6.76B	7.14B	7.67B
Machinery, Total	2.61B	2.76B	2.94B	3.07B	3.26B
Full Time Employees	68.1K	68.3K	71.2K	73.35K	76K
Part Time Employees	20.9K	21.1K	22.6K	23.35K	23K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	944M	992M	676M	718M	1.14B
Depreciation & Amortization - CF	510M	533M	582M	568M	585M
Depreciation & Amortization, Total	510M	533M	582M	568M	585M
(Gain) Loss From Sale Of Asset	1.96M	-5.17M	584K	-6.25M	-9.92M
Asset Writedown & Restructuring Costs	-	14.39M	57.55M	-	-
Stock-Based Compensation (CF)	65.84M	73.69M	85.38M	87.72M	99.35M
Other Operating Activities, Total	10.2M	12.87M	-18.63M	1.51M	24.17M
Change In Accounts Receivable	-146M	-8.87M	-258M	-182M	67.36M
Change In Income Taxes	9.59M	-54.03M	-29.51M	-43.45M	12.65M
Change in Other Net Operating Assets	964M	-674M	-98.48M	125M	147M
Cash from Operations	2.36B	884M	996M	1.27B	2.07B
Capital Expenditure	-731M	-856M	-734M	-743M	-944M
Sale of Property, Plant, and Equipment	8.17M	25.42M	12M	24.19M	38.56M
Cash Acquisitions	-52.01M	-105M	-20.31M	-3.73M	-19M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-2.9M	19.73M	-	-	-
Investment in Marketable and Equity Securities, Total	-2.67M	-	-	-	-
Other Investing Activities, Total	-21.84M	1.46M	95.01M	-40.68M	13.14M
Cash from Investing	-803M	-914M	-647M	-763M	-911M
Long-Term Debt Issued, Total	802M	3.25B	705M	185M	2.21B
Total Debt Issued	802M	3.25B	705M	185M	2.21B
Long-Term Debt Repaid, Total	-963M	-3.04B	-89.37M	-85.48M	-2.64B
Total Debt Repaid	-963M	-3.04B	-89.37M	-85.48M	-2.64B
Issuance of Common Stock	12.32M	13.37M	14.07M	13.65M	15.07M
Repurchase of Common Stock	-207M	-1.22B	-833M	-547M	-671M
Common Dividends Paid	-17.34M	-65.9M	-58.45M	-55.48M	-53.35M
Common & Preferred Stock Dividends Paid	-17.34M	-65.9M	-58.45M	-55.48M	-53.35M
Other Financing Activities, Total	-12.15M	-12.66M	-57.06M	-4.38M	-6.09M
Cash from Financing	-385M	-1.07B	-318M	-494M	-1.14B
Foreign Exchange Rate Adjustments	739K	-499K	-8.42M	3.06M	-833K
Net Change in Cash	1.17B	-1.1B	21.9M	13.63M	10.28M
Supplemental Items
Cash Interest Paid	113M	75.61M	120M	200M	168M
Cash Income Tax Paid (Refund)	286M	363M	251M	258M	325M
Levered Free Cash Flow	1.09B	280M	125M	310M	959M
Unlevered Free Cash Flow	1.16B	334M	204M	440M	1.08B
Change In Net Working Capital	-467M	309M	392M	208M	-282M
Net Debt Issued / Repaid	-161M	217M	616M	99.62M	-430M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.76	6.56	4.99	5.35	7.41
Return on Total Capital	8.29	8.16	6.03	6.44	9.04
Return On Equity %	15.89	15.67	10.8	11.82	17.94
Return on Common Equity	15.92	15.95	11.24	11.89	17.82
Margin Analysis
Gross Profit Margin %	40.3	39.95	38.53	39.5	42.47
SG&A Margin	1	0.94	0.98	0.99	0.93
EBITDA Margin %	16.18	15.25	12.26	12.21	14.34
EBITA Margin %	11.76	11.03	7.92	8.23	10.65
EBIT Margin %	11.76	11.03	7.92	8.23	10.65
Income From Continuing Operations Margin %	8.24	7.81	4.9	5.04	7.35
Net Income Margin %	8.17	7.84	5.04	5.03	7.22
Net Avail. For Common Margin %	8.14	7.83	5.04	5.02	7.22
Normalized Net Income Margin	6.72	6.58	4.45	4.1	5.79
Levered Free Cash Flow Margin	9.44	2.22	0.93	2.17	6.06
Unlevered Free Cash Flow Margin	10.03	2.64	1.52	3.08	6.8
Asset Turnover
Asset Turnover	0.92	0.95	1.01	1.04	1.11
Fixed Assets Turnover	2.09	2.12	2.12	2.21	2.34
Receivables Turnover (Average Receivables)	7.03	7.27	7.12	6.71	7.17
Inventory Turnover (Average Inventory)	39.4	38.22	38.73	39.68	41.59
Short Term Liquidity
Current Ratio	1.32	1.14	1.33	1.4	1.27
Quick Ratio	1.19	0.94	1.11	1.17	1.04
Operating Cash Flow to Current Liabilities	0.95	0.45	0.52	0.63	0.94
Days Sales Outstanding (Average Receivables)	52.08	50.17	51.27	54.38	51.06
Days Outstanding Inventory (Average Inventory)	9.29	9.55	9.42	9.2	8.8
Average Days Payable Outstanding	26.86	29.49	28.66	26.42	25.03
Cash Conversion Cycle (Average Days)	34.51	30.23	32.03	37.16	34.83
Long Term Solvency
Total Debt/Equity	65.47	73.56	88.3	86.53	73.27
Total Debt / Total Capital	39.57	42.38	46.89	46.39	42.29
LT Debt/Equity	59.35	71.74	85.8	83.33	71.58
Long-Term Debt / Total Capital	35.87	41.33	45.56	44.68	41.31
Total Liabilities / Total Assets	52.46	52.66	55.76	55.6	53.26
EBIT / Interest Expense	12.46	16.35	8.34	5.67	8.98
EBITDA / Interest Expense	18.2	24	13.94	9.09	12.88
(EBITDA - Capex) / Interest Expense	11.5	13.96	8.18	5.51	7.85
Total Debt / EBITDA	2.11	2.23	2.97	2.85	2.05
Net Debt / EBITDA	1.5	2.17	2.91	2.78	2
Total Debt / (EBITDA - Capex)	3.34	3.83	5.07	4.7	3.37
Net Debt / (EBITDA - Capex)	2.37	3.73	4.97	4.6	3.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.59	9.37	5.99	6.59	10.82
Gross Profit, 1 Yr. Growth %	2.64	8.45	2.21	9.28	19.14
EBITDA, 1 Yr. Growth %	3.65	3.08	-14.76	6.11	30.19
EBITA, 1 Yr. Growth %	3.49	2.57	-23.9	10.77	43.36
EBIT, 1 Yr. Growth %	3.49	2.57	-23.9	10.77	43.36
Earnings From Cont. Operations, 1 Yr. Growth %	15.13	3.66	-33.48	9.49	61.7
Net Income, 1 Yr. Growth %	15.84	5.05	-31.87	6.24	59.11
Normalized Net Income, 1 Yr. Growth %	8.68	7.42	-28.35	-1.64	56.45
Diluted EPS Before Extra, 1 Yr. Growth %	20.37	7.55	-22.67	11.93	64.42
Accounts Receivable, 1 Yr. Growth %	10.77	1.02	15.52	10.93	-2.7
Inventory, 1 Yr. Growth %	19.09	8.62	5.65	-0.7	1.82
Net Property, Plant and Equip., 1 Yr. Growth %	6.86	9.32	2.1	2.91	6.59
Total Assets, 1 Yr. Growth %	15.5	-2.84	3.06	3.51	3.6
Tangible Book Value, 1 Yr. Growth %	51.66	-13	-5.52	10.69	24.19
Common Equity, 1 Yr. Growth %	14.77	-3.6	-2.78	3.86	8.41
Cash From Operations, 1 Yr. Growth %	64.08	-62.56	12.71	27.29	63.05
Capital Expenditures, 1 Yr. Growth %	15.33	17	-14.22	1.23	27.02
Levered Free Cash Flow, 1 Yr. Growth %	72.78	-74.31	-55.56	149.01	208.93
Unlevered Free Cash Flow, 1 Yr. Growth %	58.04	-71.22	-38.82	115.44	144.6
Dividend Per Share, 1 Yr. Growth %	-66.67	300	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.59	5.41	7.67	6.29	8.68
Gross Profit, 2 Yr. CAGR %	3.49	5.5	5.28	5.68	14.1
EBITDA, 2 Yr. CAGR %	5.45	3.37	-6.27	-4.9	17.54
EBITA, 2 Yr. CAGR %	5.19	3.03	-11.66	-8.19	26.01
EBIT, 2 Yr. CAGR %	5.19	3.03	-11.66	-8.19	26.01
Earnings From Cont. Operations, 2 Yr. CAGR %	9.28	9.25	-16.96	-14.66	33.06
Net Income, 2 Yr. CAGR %	10.03	10.31	-15.4	-14.92	30.02
Normalized Net Income, 2 Yr. CAGR %	8.35	7.87	-12.28	-16.05	24.05
Diluted EPS Before Extra, 2 Yr. CAGR %	15	13.78	-8.8	-6.97	35.66
Accounts Receivable, 2 Yr. CAGR %	7.15	5.78	8.03	13.2	3.89
Inventory, 2 Yr. CAGR %	13.35	13.74	7.12	2.42	0.55
Net Property, Plant and Equip., 2 Yr. CAGR %	8.52	8.08	5.65	2.51	4.74
Total Assets, 2 Yr. CAGR %	9.38	5.93	0.06	3.28	3.55
Tangible Book Value, 2 Yr. CAGR %	24.19	14.87	-9.34	2.26	17.24
Common Equity, 2 Yr. CAGR %	8.27	5.18	-3.19	0.49	6.11
Cash From Operations, 2 Yr. CAGR %	36.07	-21.62	-35.04	19.78	44.06
Capital Expenditures, 2 Yr. CAGR %	4.87	16.16	0.18	-6.81	13.4
Levered Free Cash Flow, 2 Yr. CAGR %	53.59	-33.39	-66.24	5.04	177.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	43.83	-32.56	-58.04	14.83	129.55
Dividend Per Share, 2 Yr. CAGR %	-29.29	15.47	100	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.55	5.48	5.6	7.31	7.78
Gross Profit, 3 Yr. CAGR %	2.51	5.11	4.39	6.6	9.99
EBITDA, 3 Yr. CAGR %	2.66	4.65	-3.07	-2.31	5.6
EBITA, 3 Yr. CAGR %	2.02	4.31	-6.87	-4.74	6.51
EBIT, 3 Yr. CAGR %	2.02	4.31	-6.87	-4.74	6.51
Earnings From Cont. Operations, 3 Yr. CAGR %	7.3	7.37	-7.4	-8.94	5.6
Net Income, 3 Yr. CAGR %	7.86	8.34	-6.06	-8.73	4.82
Normalized Net Income, 3 Yr. CAGR %	4.01	7.92	-5.88	-8.87	3.31
Diluted EPS Before Extra, 3 Yr. CAGR %	12.06	12.46	0.04	-2.36	12.48
Accounts Receivable, 3 Yr. CAGR %	4.92	5.07	8.93	8.99	7.63
Inventory, 3 Yr. CAGR %	11.82	11.75	10.97	4.45	2.22
Net Property, Plant and Equip., 3 Yr. CAGR %	7.69	8.79	6.05	4.73	3.85
Total Assets, 3 Yr. CAGR %	7.79	5.14	4.97	1.2	3.39
Tangible Book Value, 3 Yr. CAGR %	35.55	10.29	7.62	-3.1	9.1
Common Equity, 3 Yr. CAGR %	8.18	4.16	2.46	-0.9	3.06
Cash From Operations, 3 Yr. CAGR %	23.68	-11.5	-11.53	-18.71	32.75
Capital Expenditures, 3 Yr. CAGR %	9.47	8.77	5	0.53	3.32
Levered Free Cash Flow, 3 Yr. CAGR %	19.05	-15.37	-41.8	-34.27	50.49
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.28	-15.87	-34.71	-27.61	47.75
Dividend Per Share, 3 Yr. CAGR %	-20.63	25.99	10.06	58.74	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.03	5.3	5.18	5.8	6.82
Gross Profit, 5 Yr. CAGR %	3.84	4.01	3.61	5.34	8.17
EBITDA, 5 Yr. CAGR %	2.43	2.57	-1	0.72	4.7
EBITA, 5 Yr. CAGR %	1.54	1.7	-3.68	-0.88	5.11
EBIT, 5 Yr. CAGR %	1.54	1.7	-3.68	-0.88	5.11
Earnings From Cont. Operations, 5 Yr. CAGR %	4.88	5.74	-3.16	-2.05	7.04
Net Income, 5 Yr. CAGR %	6.76	7.14	-2.13	-1.64	6.99
Normalized Net Income, 5 Yr. CAGR %	3.76	4.17	-2.9	-2.39	5.11
Diluted EPS Before Extra, 5 Yr. CAGR %	10.21	10.61	3.2	4.24	13
Accounts Receivable, 5 Yr. CAGR %	5.83	3.94	6.15	8.25	6.89
Inventory, 5 Yr. CAGR %	10.41	10.53	9.92	7.92	6.68
Net Property, Plant and Equip., 5 Yr. CAGR %	8.28	7.58	6.87	6.23	5.52
Total Assets, 5 Yr. CAGR %	6.99	4.88	4.63	4.39	4.4
Tangible Book Value, 5 Yr. CAGR %	40.18	31.46	15.4	7.01	11.37
Common Equity, 5 Yr. CAGR %	8.25	6.08	3.48	2.67	3.91
Cash From Operations, 5 Yr. CAGR %	17.18	-7.9	-4.4	-0.11	7.52
Capital Expenditures, 5 Yr. CAGR %	14.03	10.48	5.65	2.25	8.28
Levered Free Cash Flow, 5 Yr. CAGR %	12.02	-19.62	-28.06	-7.67	8.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.94	-18.25	-22.65	-4.72	7.97
Dividend Per Share, 5 Yr. CAGR %	-12.94	14.87	14.87	14.87	5.92